These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34367497)

  • 1. Racial differences in prevalence and severity of non-alcoholic fatty liver disease.
    Bonacini M; Kassamali F; Kari S; Lopez Barrera N; Kohla M
    World J Hepatol; 2021 Jul; 13(7):763-773. PubMed ID: 34367497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender and racial differences in nonalcoholic fatty liver disease.
    Pan JJ; Fallon MB
    World J Hepatol; 2014 May; 6(5):274-83. PubMed ID: 24868321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups.
    Smits MM; Ioannou GN; Boyko EJ; Utzschneider KM
    J Gastroenterol Hepatol; 2013 Apr; 28(4):664-70. PubMed ID: 23286209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome.
    Sarkar M; Terrault N; Duwaerts CC; Tien P; Cedars MI; Huddleston H
    Curr Opin Gynecol Obstet; 2018 Feb; 1(1):24-33. PubMed ID: 30112518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis.
    Patel P; Muller C; Paul S
    World J Hepatol; 2020 Aug; 12(8):506-518. PubMed ID: 32952877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis.
    Zeb I; Katz R; Nasir K; Ding J; Rezaeian P; Budoff MJ
    J Cardiovasc Comput Tomogr; 2013; 7(5):311-8. PubMed ID: 24268118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
    Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
    Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction: A Prospective Pilot Study.
    Duman DG; Biçakci E; Çelikel ÇA; Akbal C
    J Sex Med; 2016 Mar; 13(3):383-8. PubMed ID: 26853046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
    Iqbal U; Perumpail BJ; Akhtar D; Kim D; Ahmed A
    Medicines (Basel); 2019 Mar; 6(1):. PubMed ID: 30889791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort.
    Khoudari G; Singh A; Noureddin M; Fritze D; Lopez R; Asaad I; Lawitz E; Poordad F; Kowdley KV; Alkhouri N
    World J Hepatol; 2019 Oct; 11(10):710-718. PubMed ID: 31749901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 17. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
    Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
    J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).
    Choudhary NS; Duseja A
    Transl Gastroenterol Hepatol; 2021; 6():2. PubMed ID: 33409397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.